Scientists at The University of Texas at Austin have developed a revolutionary gene-editing method using bacterial retrons that can correct multiple disease-causing mutations at once. Unlike ...
Columnist Michael Le Page delves into a catalogue of hundreds of potentially beneficial gene mutations and variants that is ...
In this symposium, researchers will highlight how they overcome key obstacles between gene editing and clinical applications such as cell and gene therapy.
Morning Overview on MSN
Google DeepMind AI lights up the dark genome and flags risky DNA tweaks
Google DeepMind’s latest artificial intelligence model is turning the most mysterious stretches of human DNA into readable text, and in the process, it is flagging which tiny edits could tip a cell ...
Global Mice Model Market OverviewThe global mice model market is projected to grow at an approximate rate of 9% over the next five years, supported by increasing demand for personalized medicine, ...
GreenWood Investors reported 52.5% net returns in 2025, significantly outperforming the MSCI ACWI index. Read the full letter ...
Eli Lilly & Co. struck a deal worth more than $1.1 billion with German biotech Seamless Therapeutics GmbH to develop gene therapies for hearing loss.
This year marks 10 years since the UK voted to leave the European Union, with the intention to “take back control” of our ...
After 35 years of consistent pain, Allan Byamukama became one of the few individuals in the world cured of sickle cell ...
United StatesAurum Capital has launched its Investment-Driven Medical Innovation Initiative, aiming to expand research ...
The Skeletal Dysplasia Market is expanding, driven by advancements in gene sequencing and orphan drug incentives. Key ...
Advancements in genome editing technologies the growing emphasis on safe and accurate gene correction, and strong biotechnology R&D investment drive the base editing market.Austin, Texas, Jan. 21, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results